The U.S. Food and Drug Administration (FDA) has approved Lasix ONYU (furosemide injection), a new drug-device combination ...
Second-generation delivery device offers cost-effective alternative to hospital care benefiting patients, providers, and payorsLasix ONYU is the ...
Pharmaceuticals announced that its partner SQ Innovation has received approval from the U.S. Food and Drug Administration, FDA, for ...
A new study published in the European Journal of Heart Failure reveals that the speed of lymph flow in the legs may determine ...
Common medications like doxycycline, minocycline, and hydrochlorothiazide are associated with an increased risk for ...
The National Horseracing Authority of Southern Africa (NHA) confirms a Prohibited Substance finding. The presence of Furosemide, a loop diuretic classified as a Class 4 prohibited substance, was ...
Generic furosemide is used to help manage heart failure. ZyVet Animal Health has launched an FDA-approved generic form of furosemide tablets, used for managing congestive heart failure and chronic ...
Background: Sarcopenia is a disease that involves skeletal muscle mass loss and is highly prevalent in the older adult population. Moreover, the incidence of sarcopenia is increased in patients with ...
Enbumyst, a bumetanide nasal spray, is FDA-approved for edema in CHF, hepatic, and renal diseases, offering outpatient treatment. The nasal spray bridges gaps between oral and IV diuretics, providing ...
Credit: Aptar Pharma. Enbumyst is supplied in a unit-dose nasal spray containing bumetanide 0.5mg per 0.1mL. Enbumyst is not intended for chronic use and should be replaced with oral diuretics as soon ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback